Business
Plandai Biotechnology, Inc. Reaches Agreement With Deltamune to Study Commercial Potential of Phytofare in Livestock
Plandai Biotechnology, Inc. Reaches Agreement With Deltamune to Study Commercial Potential of Phytofare in Livestock.
About this update from Plandai Biotechnology, Inc.
[{"type":"text","content":"\n \n \n Plandai Biotechnology, Inc. Reaches Agreement With Deltamune to Study Commercial Potential of Phytofare in Livestock\n \n \nPlandai Biotechnology, Inc. Reaches Agreement With Deltamune to Study Commercial Potential of Phytofare in Livestock\n\nCompany Expects to Commence Clinical Trial in January 2016\n\n \n LONDON, UNITED KINGDOM--(Marketwired - Nov 18, 2015) - Plandaí Biotechnology, Inc. (OTCQB: PLPL) (\"Plandaí\" or \"the Company\"), producer of the highly bioavailable Phytofare® catechin complex, today announced that its wholly-owned subsidiary, Red Gold (Pty) Ltd., has reached an agreement with Deltamune (Pty) Ltd., a South African-based veterinary research and testing company that also develops and manufactures vaccines for treating Avian Influenza, Infectious Coryza, Egg Drop syndrome and Newcastle disease. Under the terms of the agreement, Deltamune will undertake clinical trials using Plandaí's Phytofare® Catechin Complex and Citrus Complex to determine the efficacy of the combined all-natural products in helping prevent diseases in poultry. Should the trials prove successful, the parties will move towards executing a production license and distribution agreement.\n According to Plandaí, the initial investigations will take place at Deltamune approved research facilities in South Africa. Stage II studies will then be conducted at four different commercial poultry production locations in South Africa. The investigations will be monitored by both Deltamune and North West University's pharmacology department.\n Roger Baylis-Duffield, Chief Executive Officer of Plandaí, commented, \"Poultry diseases pose a huge risk to both farmers and the public, necessitating the use of vaccines and other synthetic treatment protocols in most commercial farms. The loss from both poultry mortality and the growth delays caused by the vaccines is staggering. With more consumers demanding an 'organic' solution that doesn't result in huge losses to the industry, we view Phytofare® as a potential game changer in animal husbandry.\"\n \"Green tea catechins and citrus limonoids,\" Mr. Duffield continued, \"have demonstrably proven anti-viral and wellness properties. The Deltamune trials are designed to show that adding these all-natural products to the animals' food so...